Supply Chain Sustainability at Roche: Sustainable Operations, Supply Chains and AI in Health
Roche has spent more than a century building dual strength in pharmaceuticals and diagnostics. That mix gives the company leverage most operators want: shared data, shared infrastructure and clear lines from research to the patient.
The goal is simple-better outcomes, delivered reliably. The path is operational discipline: sustainable design, strong supply chains and AI that speeds decisions without breaking compliance.
Sustainability as an Operating System
Sustainability isn't a side project at Roche; it's built into how products are sourced, made, packaged and retired. The company focuses on three impact areas: fair access to innovation, an equitable workplace and environmental stewardship.
Targets include net zero carbon emissions by 2045, with goals validated by the Science Based Targets initiative. Governance and risk oversight follow the Task Force on Climate-related Financial Disclosures to keep decisions transparent and accountable.
Transforming Global Laboratory Supply Chains
Roche has modernised inventory control across 1,000+ labs in 50+ countries using Tecsys' cloud-based Elite platform. The system automates reagent and consumable tracking and connects to SAP for real-time visibility and automatic replenishment.
"We are proud to support Roche in providing inventory management solutions to hospitals and laboratories around the world," says Peter Brereton, President and CEO at Tecsys. The result: fewer manual errors, fewer stockouts and cleaner compliance trails-rolled out fast and scaled consistently.
- Automated usage capture and on-hand accuracy at the bench
- Real-time demand signals to central supply planning via SAP
- Standardised controls for audit and regulatory needs
- Template-driven deployments that scale to new sites quickly
For leaders building AI-first ops, see AI for Operations.
Case in Point: Direct Distribution and Cold Chain in Nigeria
In Nigeria, Roche moved to a direct buy-and-sell model. This removed multiple distributor tiers, reduced mark-ups and tightened cold chain oversight end to end.
"In 2020, one of the main problems we faced was having multiple levels of distribution," says Ladi Hameed, Country Manager, Roche Products Nigeria. "Every person in each stage would add mark-ups of between 5% and 10%." Patients were paying $200-$500 more each month for common oncology medicines, with cold chain risks along the way.
- Eliminate intermediaries to curb compounding mark-ups
- Own temperature control with monitored lanes and response playbooks
- Equip hospitals with storage infrastructure and staff training
- Tighten last-mile quality checks to protect product integrity
For practical upskilling on logistics automation and forecasting, explore the AI Learning Path for Supply Chain Managers.
AI That Shortens Discovery Cycles
On the R&D side, Genentech (a Roche company) uses a "lab in a loop" approach: experimental and clinical data trains AI models, those models suggest targets, molecules and antibody designs, and the lab feeds back new results to refine the models.
"The 'lab in a loop' is a mechanism by which you bring generative AI to drug discovery and development," says Dr Aviv Regev, Head of Genentech Research and Early Development (gRED). This loop enables fast virtual screening, better vaccine construct selection and smarter exploration of novel therapies-without waiting on long, linear cycles.
Operator Takeaways You Can Apply Now
- Make sustainability operational: embed material sourcing, energy-efficient packaging and end-of-life handling into standard work-not side projects.
- Instrument inventory at the point of use: connect benches, fridges and freezers to your ERP for clean signals and automated replenishment.
- Standardise regulatory controls: log, timestamp, temperature, chain of custody-design for audit before scale.
- Reduce tiers in distribution: fewer handoffs mean fewer mark-ups and fewer quality failures.
- Close the loop with data: feed real-world and lab results back into models and planning systems to improve the next run.
- Align goals and reporting: use SBTi-validated targets and TCFD-aligned risk reviews to keep leadership, investors and regulators on the same page.
The throughline is clear: connect data, remove friction and build sustainability into your daily operations. That's how you deliver access, reliability and speed-at scale.
Your membership also unlocks:
